Search Results
Mar 26, 2026, 13:46 ET The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid
their own examination and analysis of the Company, its subsidiaries, its securities and the offering, including the merits and risks involved.DNB Carnegie Investment Bank AB, Finland Branch (the "Sole Global Coordinator") is acting exclusively for the Company and no one else in connection
More news about: Bioretec
Mar 26, 2026, 13:42 ET The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid
their own examination and analysis of the Company, its subsidiaries, its securities and the offering, including the merits and risks involved.DNB Carnegie Investment Bank AB, Finland Branch (the "Sole Global Coordinator") is acting exclusively for the Company and no one else in connection
More news about: Bioretec
Mar 22, 2026, 21:29 ET Southeast Asia 5G Infrastructure Market to Grow at 31.14% CAGR Through 2032 Amid Rising Demand for High-Speed Connectivity | MarkNtel Advisors
CorporationQualcomm Technologies, Inc.ZTE CorporationSamsung ElectronicsAdvanced Info Service Plc (AIS)Digital Nasional Berhad (DNB)Telkomsel / Telkom GroupPLDT / Smart CommunicationsSoutheast Asia 5G Infrastructure Market ScopeBy
More news about: MarkNtel Advisors
Mar 17, 2026, 07:43 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
based in Kendall Square, Boston, Massachusetts, US. Cereno Scientific is listed on the Nasdaq First North (CRNO B). The Company's Certified Adviser is DNB Carnegie Investment Bank AB, [email protected]. More information
More news about: Cereno Scientific
Mar 17, 2026, 07:39 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
based in Kendall Square, Boston, Massachusetts, US. Cereno Scientific is listed on the Nasdaq First North (CRNO B). The Company's Certified Adviser is DNB Carnegie Investment Bank AB, [email protected]. More information
More news about: Cereno Scientific
Mar 13, 2026, 03:45 ET SciBase: Interim report
e-mail: [email protected] Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570Email: [email protected]
More news about: SciBase
Mar 10, 2026, 16:35 ET Inside information: Bioretec Ltd is planning a rights issue of at least EUR 5 million and up to EUR 15 million with a maximum of 1,500,000,000 new shares
disciplined scrutiny across our business, with the aim of generating value for our shareholders."Lead managerBioretec has appointed DNB Carnegie Investment Bank AB, Finland Branch as the lead manager for the Offering.Further enquiriesSarah van Hellenberg Hubar-Fisher,
More news about: Bioretec
Mar 10, 2026, 16:30 ET Inside information: Bioretec Ltd is planning a rights issue of at least EUR 5 million and up to EUR 15 million with a maximum of 1,500,000,000 new shares
disciplined scrutiny across our business, with the aim of generating value for our shareholders."Lead managerBioretec has appointed DNB Carnegie Investment Bank AB, Finland Branch as the lead manager for the Offering.Further enquiriesSarah van Hellenberg Hubar-Fisher,
More news about: Bioretec
Mar 10, 2026, 08:27 ET New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment
02Email: [email protected] Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570Email: [email protected]
More news about: SciBase
Mar 10, 2026, 06:05 ET Boost.ai Announces Adaptive Voice, Enabling Dynamic Agentic Experiences Through Voice
enterprise-grade reliability make boost.ai the partner of choice for leading brands across the world, including Nordea, Credit Union of Colorado, Sage, DNB, Trading 212, and more. Boost.ai is recognized as a Leader in Gartner's 2025 Magic Quadrant for Conversational AI Platforms. Learn more at
More news about: boost.ai
Mar 05, 2026, 08:58 ET Flex LNG - Company presentation March 2026
5, 2026 /PRNewswire/ -- Flex LNG Ltd ("Flex LNG") (NYSE: FLNG) participated in one-on-one investor meetings and gave a company presentation at DNB Carnegie's Energy & Shipping Conference 2026 today. The presentation used is attached hereto and is also available on our web page. For further
More news about: Flex LNG
Mar 05, 2026, 03:30 ET TORM plc - Notice of and Complete Proposals for the Annual General Meeting 2026
Bank Means (i) DnB Carnegie, Inc. or (ii) DnB Carnegie Investment Bank, Fillal AF DnB Carnegie Investment Bank AB, Sverige, as the context requires.
More news about: Torm PLC
Mar 05, 2026, 02:24 ET New Publication: US clinicians' real-world Nevisense experience improves melanoma detection
[email protected] Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570Email: [email protected]
More news about: SciBase
Mar 04, 2026, 04:28 ET Coor contemplates issuance of new senior unsecured bonds
conditional notice of early redemption of existing bonds. Coor Service Management Holding AB ("Coor") has mandated Danske Bank A/S, Danmark, Sverige Filial, DNB Carnegie Investment Bank AB (publ), and Skandinaviska Enskilda Banken AB (publ) as joint bookrunners to arrange a series of fixed income investor meetings
More news about: Coor
Mar 02, 2026, 02:21 ET SciBase receives approval by FDA for extended labelling in the US
+46732069802E-mail: [email protected] Certified Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570E-mail: [email protected]
More news about: SciBase
Feb 19, 2026, 08:14 ET SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma
+46732069802E-mail: [email protected] Certified Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570E-mail: [email protected]
More news about: SciBase
Feb 18, 2026, 05:25 ET Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion
www.enzymatica.se.Enzymatica's Certified Adviser is DNB Carnegie Investment Bank AB (publ).This information was brought to you by Cision
More news about: Enzymatica AB
Feb 17, 2026, 09:27 ET A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns
[email protected] Certified Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570E-mail: [email protected]
More news about: SciBase
Feb 13, 2026, 09:23 ET Boliden signs a EUR 1,000 million revolving credit facilities agreement
Lead Arrangers for the facilities and Danske Bank is the Facility Agent. The Bookrunners and Mandated Lead Arrangers are BNP Paribas, Danske Bank A/S, DNB Bank ASA, Sweden Branch, Nordea Bank Abp, filial i Sverige, Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ). Bank of America Europe Designated
More news about: Boliden
Feb 13, 2026, 03:22 ET Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future
made any final decisions concerning the execution of the Offering and emphasizes that the execution of the potential Offering is not yet certain.DNB Carnegie Investment Bank AB, Finland Branch has been mandated to investigate the structure and terms for a potential Offering.Further enquiriesSarah
More news about: Bioretec
Feb 13, 2026, 03:13 ET Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future
made any final decisions concerning the execution of the Offering and emphasizes that the execution of the potential Offering is not yet certain.DNB Carnegie Investment Bank AB, Finland Branch has been mandated to investigate the structure and terms for a potential Offering.Further enquiriesSarah
More news about: Bioretec
Feb 13, 2026, 01:36 ET Elkem announces agreement to sell majority of Silicones division to Bluestar
employee representatives on the Board of Directors of Elkem (the "Independent Board") has as part of the Contemplated Transaction engaged DNB Carnegie, a part of DNB Bank ASA ("DNBC") to provide a fairness opinion. DNBC has concluded that the Contemplated Transaction is fair from a financial point of view
More news about: Elkem
Feb 13, 2026, 01:31 ET Elkem announces agreement to sell majority of Silicones division to Bluestar
employee representatives on the Board of Directors of Elkem (the "Independent Board") has as part of the Contemplated Transaction engaged DNB Carnegie, a part of DNB Bank ASA ("DNBC") to provide a fairness opinion. DNBC has concluded that the Contemplated Transaction is fair from a financial point of view
More news about: Elkem
Feb 06, 2026, 02:17 ET SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue
publication, through the agency of the contact person set out above, on February 6, 2026 at 08.00 CET.Certified Advisor (CA):DNB Carnegie Investment Bank AB (publ) Phone: +46 8 588 68 570, E-mail: [email protected]
More news about: SciBase
Feb 04, 2026, 04:38 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
based in Kendall Square, Boston, Massachusetts, US. Cereno Scientific is listed on the Nasdaq First North (CRNO B). The Company's Certified Adviser is DNB Carnegie Investment Bank AB, [email protected]. More information
More news about: Cereno Scientific